Jazz Pharmaceuticals JAZZ Earnings Call Transcripts

NASDAQ JAZZ
$243.54 +8.78 (+3.74%)
At close: Nov 9, 2026 · 4:00 PM EST
10 earnings calls on file for Jazz Pharmaceuticals, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Jazz Pharmaceuticals Q3 2026 Earnings Call

Nov 2, 2026 8,290 words · 36 min read
  • John BluthHead of Investor Relations
  • Renée GaláPresident and Chief Executive Officer
  • Samantha PearceChief Commercial Officer
  • Robert IannoneGlobal Head of R&D and Chief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Jazz Pharmaceuticals Earnings Call Transcripts

Calls10
LatestNov 2, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 10 Jazz Pharmaceuticals transcripts Register to get access to Jazz Pharmaceuticals’s earnings call transcripts.